MYGN

Myriad Genetics Inc

Healthcare, Event Driven/Special Sit


Presented:04/04/2013
Price:$24.35
Cap:$1.96B
Current Price:$23.98
Cap:$2.18B

Presented

Date04/04/2013
Price$24.35
Market Cap$1.96B
Ent Value$1.60B
P/E Ratio24.17x
Book Value$9.71
Div YieldN/A
Shares O/S80.58M
Ave Daily Vol1,010,000
Short Int7.04%

Current

Price$23.98
Market Cap$2.18B

Highlights

The presenter’s bearish point of view on MYGN’s patent case under review by the Supreme Court (SCOTUS) is one of the main drivers behind is short position in MYGN shares and derivatives. He likes the put options in particular as the premium does not seem to reflect the volatility that might develop as the date of the announcement approaches. In addition to the patent risk, the presenter sees competitive and reimbursement risks looming, and summarized his sentiment as follows:

  • Signing up and creating account with us unlocks this content for you. Contact us today for full access to DeMatteo Research and more.

  • Signing up and creating account with us unlocks this content for you. Contact us today for full access to DeMatteo Research and more.

Request access to DeMatteo Research for full access

Request Access

Already have an account?

Idea Discussion

Commentor 1 - 2 weeks ago

Signing up and creating account with us, unlocks this content for you. Contact us today for full access to DeMatteo Research and more.

Commentor 1 - 2 weeks ago

Signing up and creating account with us, unlocks this content for you. Contact us today for full access to DeMatteo Research and more.

Idea Discussions display submitted commentary from our investor community.

To read and participate in the discussion with the presenter and investor base, request access to DeMatteo

Request Access

Already have an account?

An error occurred loading this content. Try again later or contact us.